Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-18

Biomarkers in age-related macular degeneration

Objective

Age-related macular degeneration (AMD) is the leading cause of blindness in all populations of European origin with a large socio-economic impact on health systems. Better understanding of the disease should allow to improve diagnosis and disease monitoring and to develop new therapies. Aging and genetic predisposition are the most important risk factors for AMD. Many of the risk genes code for proteins of the innate immune system. Consistently, altered blood concentrations of immune-proteins have been detected in AMD strongly suggesting that such proteins can be used as biomarkers for AMD. Other proteins have also been found to be altered in AMD. We hypothesise that a combination of biomarkers, such as complement activation products, cytokines and elastin degradation products, are highly discriminative for AMD and allow an estimation of disease progression. This would enable clinicians to better allocate personal and financial resources for early identification and therapeutic monitoring of AMD patients at risk. Protein microarray will be used to quantify a large number of biomarkers. Logistic models will define the most relevant proteins and correlation with genetic markers will define biologically meaningful genetic polymorphisms. The relevant proteins will be analysed in blood samples of a large population based cohort. In 2008, all of these patients are being re-examined 6 years after baseline. The six year gap allows a significant number of patients with early AMD at baseline to have developed end-stage AMD, allowing the correlation of baseline systemic biomarkers with disease progression. The relevant biomarkers will furthermore be studied in animal models for AMD in order to better characterize and compare these models regarding systemic alterations observed in AMD patients.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP7-PEOPLE-IEF-2008
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

MC-IEF - Intra-European Fellowships (IEF)

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
EU contribution
€ 171 300,62
Address
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
United Kingdom

See on map

Region
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0